Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma

INTRODUCTION: The objective of this study was to evaluate real-world effectiveness of latanoprostene bunod (LBN) ophthalmic solution 0.024% in treatment-naïve patients newly diagnosed with open-angle glaucoma (OAG) or ocular hypertension. METHODS: This multicenter retrospective chart review included...

Descripción completa

Detalles Bibliográficos
Autores principales: Okeke, Constance O., Burstein, Eitan S., Trubnik, Valerie, Deom, James E., Cooper, Michael S., Brinkley, Desirae A., Thimons, J. James, Kabiri, Alexander J., Gelb, Kerry M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708554/
https://www.ncbi.nlm.nih.gov/pubmed/33034885
http://dx.doi.org/10.1007/s40123-020-00307-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708554/
https://www.ncbi.nlm.nih.gov/pubmed/33034885
http://dx.doi.org/10.1007/s40123-020-00307-0

Ejemplares similares